Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Peter Levy currently holds 285,724 shares of Atlas Therapeutics Corp (ATTH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter Levy has been a net buyer of ATTH stock. They have purchased $94.9K and sold $3.1K worth of shares.
Peter Levy's most recent insider trade was on Feb 2, 2023, when they sold 136,364 shares at $0.00 per share.
Peter Levy serves as Executive at Atlas Therapeutics Corp (ATTH). They have executed 19 insider transactions totaling $98.0K over their tenure at the company.
Peter Levy holds the position of Executive at Atlas Therapeutics Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Peter Levy has shown a buying trading pattern, with $94.9K in total purchases and $3.1K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Peter Levy was on May 20, 2022, when they purchased $94.9K worth of RMBL shares. This transaction involved 6,500 shares at $14.60 per share.
Peter Levy currently owns 285,724 shares of Atlas Therapeutics Corp (ATTH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Peter Levy's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Peter Levy has 19 Form 4 filings on record as an insider at Atlas Therapeutics Corp.
Set alerts for Peter Levy and 40,000+ other insiders.